Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 514

1.

Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer?

Lee DW, Lee KH, Lee JW, Park ST, Park JS, Lee HN.

Int J Gynecol Cancer. 2013 Sep;23(7):1303-10. doi: 10.1097/IGC.0b013e31829da105.

PMID:
23881101
2.

Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer: long-term results.

Mori T, Hosokawa K, Sawada M, Kuroboshi H, Tatsumi H, Koshiba H, Okubo T, Kitawaki J.

Int J Gynecol Cancer. 2010 May;20(4):611-6. doi: 10.1111/IGC.0b013e3181d80aa9.

PMID:
20686381
3.

[Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].

Hu JL, Wu LY, Li N, Li XG, Huang MN, Zhang R.

Zhonghua Fu Chan Ke Za Zhi. 2012 Jun;47(6):452-7. Chinese.

PMID:
22932113
4.

Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.

Guo L, Liu X, Wang L, Sun H, Huang K, Li X, Tang F, Li S, Yuan X, Wang C.

Int J Gynecol Cancer. 2015 Jun;25(5):910-8. doi: 10.1097/IGC.0000000000000430. Erratum in: Int J Gynecol Cancer. 2016 May;26(4):807.

PMID:
25867278
5.

Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.

Hwang YY, Moon H, Cho SH, Kim KT, Moon YJ, Kim SR, Kim DS.

Gynecol Oncol. 2001 Jul;82(1):88-93.

PMID:
11426967
6.

Neoadjuvant paclitaxel and cisplatin in uterine cervical cancer: long-term results.

Park DC, Suh MJ, Yeo SG.

Int J Gynecol Cancer. 2009 Jul;19(5):943-7. doi: 10.1111/IGC.0b013e3181a23c2e.

PMID:
19574789
7.

Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.

Landoni F, Sartori E, Maggino T, Zola P, Zanagnolo V, Cosio S, Ferrari F, Piovano E, Gadducci A.

Gynecol Oncol. 2014 Mar;132(3):611-7. doi: 10.1016/j.ygyno.2013.12.010. Epub 2013 Dec 14.

PMID:
24342439
8.

Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?

Moioli M, Papadia A, Mammoliti S, Pacella E, Menoni S, Menada MV, Ragni N.

Minerva Ginecol. 2012 Apr;64(2):95-107. English, Italian.

PMID:
22481620
9.

[Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].

Wang D, Wu M, Ren T, Wan XR, Feng FZ, Huang HF, Yang JX, Shen K, Xiang Y.

Zhonghua Fu Chan Ke Za Zhi. 2012 Aug;47(8):577-81. Chinese.

PMID:
23141176
10.

Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.

Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T.

Int J Gynecol Cancer. 2013 Mar;23(3):567-75. doi: 10.1097/IGC.0b013e31828703fd.

PMID:
23385284
12.

Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.

Minig L, Colombo N, Zanagnolo V, Landoni F, Bocciolone L, Cárdenas-Rebollo JM, Iodice S, Maggioni A.

Int J Gynecol Cancer. 2013 Nov;23(9):1647-54. doi: 10.1097/IGC.0b013e3182a616d2.

PMID:
24100590
13.

Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.

Zheng M, Huang L, Liu JH, Xiong Y, Li JD, Huang X, He L, Ren YF, Wang HY.

J Surg Oncol. 2011 Oct;104(5):480-5. doi: 10.1002/jso.21956. Epub 2011 May 2.

PMID:
21538358
15.

Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.

Lee HN, Lee KH, Lee DW, Lee YS, Park EK, Park JS.

Int J Gynecol Cancer. 2011 Jan;21(1):128-36. doi: 10.1097/IGC.0b013e318200f7c5.

PMID:
21330837
16.

The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.

Yin M, Zhang H, Li H, Li X, Liu Y, Chen X, Lou G, Li K.

J Surg Oncol. 2012 Feb;105(2):206-11. doi: 10.1002/jso.22052. Epub 2011 Aug 3.

PMID:
21815150
17.

The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.

Yin YJ, Li HQ, Sheng XG, Du XL, Wang C, Lu CH, Pan CX.

Int J Gynecol Cancer. 2015 Jul;25(6):1058-65. doi: 10.1097/IGC.0000000000000360.

PMID:
25647254
18.

[Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].

Cheng XD, Lü WG, Ye F, Chen HZ, Xie X.

Zhonghua Fu Chan Ke Za Zhi. 2006 Feb;41(2):95-8. Chinese.

PMID:
16640856
19.

A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix.

Tabata T, Nishiura K, Yanoh K, Okugawa T, Obata H, Tanaka K, Toyoda N.

Int J Clin Oncol. 2004 Feb;9(1):59-63.

PMID:
15162828
20.

[Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].

Zhang R, Li B, Bai P, Li HJ, Li SM, Wu LY, Li W.

Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):616-20. Chinese.

PMID:
22325224

Supplemental Content

Support Center